151 related articles for article (PubMed ID: 3514336)
1. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
2. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
3. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
4. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
5. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
6. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
7. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
8. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
[TBL] [Abstract][Full Text] [Related]
9. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
11. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?
Atkinson MA; Maclaren NK; Riley WJ; Winter WE; Fisk DD; Spillar RP
Diabetes; 1986 Aug; 35(8):894-8. PubMed ID: 3525287
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
13. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
15. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
16. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
18. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
[TBL] [Abstract][Full Text] [Related]
19. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
